Skip to main content
Caplight Logo









MetaDeq

MetaDeq

Private
LondonHealthcare & Life Scienceshttps://metadeq.com/

Company Overview

MetaDeq operates in Healthcare & Life Sciences and is based in London. It was founded in 2019.

MetaDeq is a diagnostics company that develops non-invasive, blood-based diagnostic tests for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MetaDeq Comparables

Compare MetaDeq with similar companies based on industry and business-model similarity.

MetaDeq comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hepta Bio
87%
Fibronostics
86%
AGED Diagnostics
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MetaDeq Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for MetaDeq. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

David Nikodem

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

MetaDeq Filings

Explore SEC and related filing metadata, where available.

MetaDeq filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MetaDeq's valuation, stock price, and market status.

Is MetaDeq a public or private company?

MetaDeq is a private company.

What is the current stock price of MetaDeq?

MetaDeq is a private company, so its shares have no public market price. Caplight tracks MetaDeq's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MetaDeq worth (valuation)?

Valuation information for MetaDeq is not publicly available.

Can I buy MetaDeq stock?

MetaDeq shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MetaDeq's last funding round?

Funding round information for MetaDeq is not publicly available.

Who are the main investors in MetaDeq?

Investor information for MetaDeq is not publicly disclosed.

Will MetaDeq IPO soon?

No public IPO plans have been announced for MetaDeq.

How can I track MetaDeq secondary market activity?

Caplight tracks bids, offers, and trades in MetaDeq's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range7
Year Founded2019
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?